Loading…
Loading…
The sale was valued at approximately $110,000. This acquisition increased her direct equity holdings in the company by 9%.
The transaction involved 10,000 shares executed at a weighted average price of $16.234 per share, resulting in a total value of ~$162,300 on August 31, 2026. The executive traded shares equal to 0.52% of the stake held before the filing.
Rising long-term Treasury yields are pressuring the most capital-hungry corners of the AI infrastructure trade Tuesday morning, and the pain is landing on the pure-play buildout names rather than the broader data center category.
On August 28, 2026, Core Scientific Inc (CORZ) shares fell 6.3%, closing at $16.51. This decline is part of a broader trend, with the stock down 20.4% over the
AI data center pure plays are unwinding together Friday, with a fiscal 2026 impairment charge at IREN Limited (NASDAQ:IREN) dragging capex-heavy peers. The broadening move signals investors re-pricing the group's transition costs across the cohort.
Core Scientific, Inc. (Nasdaq: CORZ) (âCore Scientificâ or the âCompanyâ), a leader in digital infrastructure for high-density colocation (âHDCâ), t
MIAMI--(BUSINESS WIRE)--Core Scientific, Inc. (Nasdaq: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for high-density colocation (“HDC”), today announced that it has entered into $600 million of committed senior secured credit facilities, consisting of a $100 million revolving credit facility and $500 million letter of credit facility.The proceeds of borrowings under the revolving credit facility may be used for general corporate purposes and working capital need.
Avala Global LP acquired a new stake in Core Scientific, Inc. (NASDAQ: CORZ) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,975,334 shares of the company's stock, valued at approximately $101,729,000. Core Scientific makes up 3.8% of Avala